Skip to main content
. 2020 Dec 16;33(3):e1524. doi: 10.1590/0102-672020200003e1524

TABLE 2. Distribution of the number of metastasis sites, according to the type of KRAS mutation.

Number of metastatic sites
Mutation type Only one More than one Total
n % n % n %
p.G12A 3 12.5% - - 3 10.0%
p.G12C 1 4.2% - - 1 3.3%
p.G12D 7 29.2% - - 7 23.3%
p.G12V 8 33.3% 2 33.3% 10 33.3%
p.G13C - - 1 16.7% 1 3.3%
p.G13D 4 16.7% 3 50.0% 7 23.3%
p.G12W 1 4.2% - - 1 3.3%
Total 24 100% 6 100% 30 100%

n=mutation number